Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00344812Phase 2Completed
A Phase 2 trial of levacetylmethadol, buprenorphine in opioid use disorder (OUD), sponsored by Johns Hopkins University. Started Jan 1996; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00344812.